{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:58:39Z","timestamp":1781013519863,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.arbres.2025.11.010","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T08:14:10Z","timestamp":1764749650000},"page":"360-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Invasive Fungal Infections: No Trial, No Error, Just Uncertainty\u2014Immunosuppression Diversifies, but Evidence Remains Anchored in Classical Models"],"prefix":"10.1016","volume":"62","author":[{"given":"Amparo","family":"Sol\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Orla","family":"Morrissey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2025.11.010_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101215","article-title":"The changing epidemiology of fungal infections","volume":"94","author":"Lass-Fl\u00f6rl","year":"2023","journal-title":"Mol Aspects Med"},{"issue":"8","key":"10.1016\/j.arbres.2025.11.010_bib0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cmi.2016.05.016","article-title":"New clinical phenotypes of fungal infections in special hosts","volume":"22","author":"Pilmis","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.arbres.2025.11.010_bib0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cmi.2024.08.006","article-title":"Invasive fungal disease in the immunocompromised host: changing epidemiology, new antifungal therapies, and management challenges","volume":"31","author":"Giannella","year":"2025","journal-title":"Clin Microbiol Infect"},{"issue":"16","key":"10.1016\/j.arbres.2025.11.010_bib0070","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMra2027424","article-title":"Aspergillus infections","volume":"385","author":"Thompson","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2025.11.010_bib0075","article-title":"The changing epidemiology of invasive mold diseases in immunosuppressed patients: what, why, how?","author":"Apostolopoulou","year":"2025","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.arbres.2025.11.010_bib0080","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00920-22","article-title":"Active surveillance program to increase awareness on invasive fungal diseases: the French RESSIF Network (2012\u20132018)","volume":"13","author":"Bretagne","year":"2022","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.arbres.2025.11.010_bib0085","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S2666-5247(22)00261-0","article-title":"The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey","volume":"4","author":"Salmanton-Garcia","year":"2023","journal-title":"Lancet Microbe"},{"issue":"6","key":"10.1016\/j.arbres.2025.11.010_bib0090","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cmi.2024.03.006","article-title":"New treatment options for critically important WHO fungal priority pathogens","volume":"31","author":"Kriegl","year":"2025","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.arbres.2025.11.010_bib0095","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/jac\/dkae158","article-title":"Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases\u2014a debate","volume":"79","author":"Maertens","year":"2024","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.arbres.2025.11.010_bib0100","doi-asserted-by":"crossref","first-page":"i17","DOI":"10.1093\/jac\/dkaf005","article-title":"Diagnosis and management of invasive fungal infections due to non-Aspergillus moulds (2)","volume":"80","author":"Morrissey","year":"2025","journal-title":"J Antimicrob Chemother"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030028962500417X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030028962500417X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:00:54Z","timestamp":1781010054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030028962500417X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S030028962500417X"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2025.11.010","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive Fungal Infections: No Trial, No Error, Just Uncertainty\u2014Immunosuppression Diversifies, but Evidence Remains Anchored in Classical Models","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2025.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}